Literature DB >> 23319611

Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides.

Chihiro Matsushita1, Hiroko Tamagaki, Yudai Miyazawa, Saburo Aimoto, Steven O Smith, Takeshi Sato.   

Abstract

The transmembrane (TM) and juxtamembrane (JM) regions of the ErbB family receptor tyrosine kinases connect the extracellular ligand-binding domain to the intracellular kinase domain. Evidence for the role of these regions in the mechanism of receptor dimerization and activation is provided by TM-JM peptides corresponding to the Neu (or rat ErbB2) receptor. Solid-state NMR and fluorescence spectroscopy show that there are tight interactions of the JM sequence with negatively charged lipids, including phosphatidylinositol 4,5-bisphosphate, in TM-JM peptides corresponding to the wild-type receptor sequence. We observe a release of the JM sequence from the negatively charged membrane surface using peptides containing an activating V664E mutation within the TM domain or in peptides engineered to form TM helix dimers with Val664 in the interface. These results provide the basis of a mechanism for coupling ligand binding to kinase activation in the full-length receptor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319611      PMCID: PMC3562775          DOI: 10.1073/pnas.1215207110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization.

Authors:  M J Sternberg; W J Gullick
Journal:  Protein Eng       Date:  1990-03

2.  Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.

Authors:  C I Bargmann; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

4.  Activation of the EGF receptor by insertional mutations in its juxtamembrane regions.

Authors:  A Sorokin
Journal:  Oncogene       Date:  1995-10-19       Impact factor: 9.867

5.  Structural analysis of the transmembrane domain of the epidermal growth factor receptor.

Authors:  C D Carpenter; H A Ingraham; C Cochet; G M Walton; C S Lazar; J M Sowadski; M G Rosenfeld; G N Gill
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

6.  Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions.

Authors:  O Kashles; D Szapary; F Bellot; A Ullrich; J Schlessinger; A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 7.  The ErbB receptors and their role in cancer progression.

Authors:  Thomas Holbro; Gianluca Civenni; Nancy E Hynes
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

8.  Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.

Authors:  Nadine Seubert; Yohan Royer; Judith Staerk; Katharina F Kubatzky; Virginie Moucadel; Shyam Krishnakumar; Steven O Smith; Stefan N Constantinescu
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

9.  Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.

Authors:  C I Bargmann; R A Weinberg
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

10.  A subdomain in the transmembrane domain is necessary for p185neu* activation.

Authors:  H Cao; L Bangalore; B J Bormann; D F Stern
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  20 in total

1.  A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.

Authors:  Lisa M Petti; Kristina Talbert-Slagle; Megan L Hochstrasser; Daniel DiMaio
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

Review 2.  Juxtamembrane contribution to transmembrane signaling.

Authors:  Wei Deng; Renhao Li
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

3.  Basic motifs target PSGL-1, CD43, and CD44 to plasma membrane sites where HIV-1 assembles.

Authors:  Jonathan R Grover; Sarah L Veatch; Akira Ono
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

Review 4.  Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them.

Authors:  Justin M Westerfield; Francisco N Barrera
Journal:  J Biol Chem       Date:  2019-12-25       Impact factor: 5.157

5.  Lipid-Protein Interplay in Dimerization of Juxtamembrane Domains of Epidermal Growth Factor Receptor.

Authors:  Ryo Maeda; Takeshi Sato; Kenji Okamoto; Masataka Yanagawa; Yasushi Sako
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

6.  Understanding Membrane Domain-Partitioning Thermodynamics of Transmembrane Domains with Potential of Mean Force Calculations.

Authors:  Xubo Lin; Alemayehu A Gorfe
Journal:  J Phys Chem B       Date:  2019-01-24       Impact factor: 2.991

Review 7.  Putting together structures of epidermal growth factor receptors.

Authors:  Nicholas J Bessman; Daniel M Freed; Mark A Lemmon
Journal:  Curr Opin Struct Biol       Date:  2014-10-24       Impact factor: 6.809

Review 8.  Lipid interaction sites on channels, transporters and receptors: Recent insights from molecular dynamics simulations.

Authors:  George Hedger; Mark S P Sansom
Journal:  Biochim Biophys Acta       Date:  2016-03-03

Review 9.  Solid state NMR and protein-protein interactions in membranes.

Authors:  Yimin Miao; Timothy A Cross
Journal:  Curr Opin Struct Biol       Date:  2013-09-11       Impact factor: 6.809

Review 10.  The EGFR family: not so prototypical receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger; Kathryn M Ferguson
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-04-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.